BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Reddy ST, Cossey T, Savitz SI, Grotta JC. Non-Vitamin K Oral Anticoagulants (NOACs) and Their Reversal. Curr Neurol Neurosci Rep 2017;17. [DOI: 10.1007/s11910-017-0774-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Lipari L, Yang S, Milligan B, Blunck J. Emergent reversal of oral factor Xa inhibitors with four-factor prothrombin complex concentrate. The American Journal of Emergency Medicine 2020;38:2641-5. [DOI: 10.1016/j.ajem.2020.08.019] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Peacock WF, Grotta JC, Steiner T. Idarucizumab for Reversal of Dabigatran in Early/Emergency Surgeries: A Case Series. J Emerg Med 2019;57:e167-73. [PMID: 31662218 DOI: 10.1016/j.jemermed.2019.09.038] [Reference Citation Analysis]
3 Dabi A, Koutrouvelis AP. Reversal Strategies for Intracranial Hemorrhage Related to Direct Oral Anticoagulant Medications. Crit Care Res Pract 2018;2018:4907164. [PMID: 30073093 DOI: 10.1155/2018/4907164] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]